Literature DB >> 25749865

CORR Insights(®): Are Allogeneic Blood Transfusions Associated With Decreased Survival After Surgery for Long-bone Metastatic Fractures?

R Lor Randall1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25749865      PMCID： PMC4457750          DOI： 10.1007/s11999-015-4225-x

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  6 in total

1.  A promise to our patients with metastatic bone disease.

Authors:  R Lor Randall
Journal:  Ann Surg Oncol       Date:  2014-08-26       Impact factor: 5.344

2.  Allogeneic versus autologous blood transfusion and survival after radical prostatectomy.

Authors:  Heather J Chalfin; Steven M Frank; Zhaoyong Feng; Bruce J Trock; Charles G Drake; Alan W Partin; Elizabeth Humphreys; Paul M Ness; Byong C Jeong; Seung B Lee; Misop Han
Journal:  Transfusion       Date:  2014-03-06       Impact factor: 3.157

Review 3.  Erythropoietin use in CKD patients with cancer: to tread with caution?

Authors:  Shobhana Nayak-Rao; Brendan McCormick
Journal:  J Nephrol       Date:  2013-09-18       Impact factor: 3.902

Review 4.  Current status of use of erythropoietic agents in cancer patients.

Authors:  John Glaspy
Journal:  Semin Thromb Hemost       Date:  2014-03-27       Impact factor: 4.180

5.  Blood transfusions and prognosis in colorectal cancer: long-term results of a randomized controlled trial.

Authors:  Joris J Harlaar; Martijn P Gosselink; Wim C J Hop; Johan F Lange; Olivier R C Busch; Hans Jeekel
Journal:  Ann Surg       Date:  2012-11       Impact factor: 12.969

6.  Economic burden of metastatic bone disease in the U.S.

Authors:  Kathy L Schulman; Joseph Kohles
Journal:  Cancer       Date:  2007-06-01       Impact factor: 6.860
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.